SEC Form 5 · accession 0001209191-15-013522

VERTEX PHARMACEUTICALS INC / MA · VRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 31, 2014

Accepted (ET)

Feb 13, 2015 · 4:17 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000875320

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Nov 22, 2011	P	31	$28.00	A	1,088	D
Common Stock^F1	Dec 6, 2011	P	33	$29.66	A	1,088	D
Common Stock^F1	Dec 7, 2011	P	9	$29.19	A	1,088	D
Common Stock^F1	Aug 10, 2012	P	15	$51.23	A	1,088	D

No Table II lines on this filing.